David Arkowitz is Director of iBio, Inc.. Currently has a direct ownership of 18,382 shares of IBIO, which is worth approximately $50,182. The most recent transaction as insider was on Jan 10, 2025, when has been sold 18,382 shares (Common Stock) at a price of $2.72 per share, resulting in proceeds of $49,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K
n/a 3M change
n/a 12M change
Total Value Held $50,182

David Arkowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
BUY
Open market or private purchase
$49,999 $2.72 p/Share
18,382 Added 50.0%
18,382 Common Stock

Also insider at

FSTX
F-star Therapeutics, Inc. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
FLXN
Flexion Therapeutics Inc
MCRB
Seres Therapeutics, Inc. Healthcare
DA

David Arkowitz

Director
Cambridge, MA

Track Institutional and Insider Activities on IBIO

Follow iBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBIO shares.

Notify only if

Insider Trading

Get notified when an I Bio, Inc. insider buys or sells IBIO shares.

Notify only if

News

Receive news related to iBio, Inc.

Track Activities on IBIO